Lithium niobate nanoparticles as biofunctional interface material for inner ear devices.
Animals
Anti-Bacterial Agents
/ pharmacology
Cell Line
Cell Survival
Ear, Inner
/ physiology
Humans
Immunologic Factors
/ pharmacology
Mice
Microbial Sensitivity Tests
Nanoparticles
/ chemistry
Niobium
/ chemistry
Oxides
/ chemistry
Pseudomonas aeruginosa
/ drug effects
Rats
Spectroscopy, Fourier Transform Infrared
Staphylococcus aureus
/ drug effects
Temperature
Journal
Biointerphases
ISSN: 1559-4106
Titre abrégé: Biointerphases
Pays: United States
ID NLM: 101275679
Informations de publication
Date de publication:
20 05 2020
20 05 2020
Historique:
entrez:
22
5
2020
pubmed:
22
5
2020
medline:
9
6
2021
Statut:
epublish
Résumé
Sensorineural hearing loss (SNHL) affects the inner ear compartment and can be caused by different factors. Usually, the lack, death, or malfunction of sensory cells deputed to transduction of mechanic-into-electric signals leads to SNHL. To date, the therapeutic option for patients impaired by severe or profound SNHL is the cochlear implant (CI), a high-tech electronic device replacing the entire cochlear function. Piezoelectric materials have catalyzed attention to stimulate the auditory neurons by simply mimicking the function of the cochlear sensory epithelium. In this study, the authors investigated lithium niobate (LiNbO
Substances chimiques
Anti-Bacterial Agents
0
Immunologic Factors
0
Oxides
0
Niobium
05175J654G
lithium niobate
12031-63-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM